Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. (Q40235280)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

27 December 2019

main subject

phase III clinical trial

0 references

0 references

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Simon Nadel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Brahm Goldstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mark D Williams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Heidi Dalton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

William L Macias

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Shamel A Abd-Allah

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Howard Levy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Robinette Angle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Dazhe Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

David P Sundin

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Brett Giroir

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

REsearching severe Sepsis and Organ dysfunction in children: a gLobal perspective (RESOLVE) study group

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

836-843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

9564

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

Advances in the therapy for sepsis in children

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

1 reference

7 January 2021

Sepsis in neonates and children: definitions, epidemiology, and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

The epidemiology of severe sepsis in children in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

PRISM III: an updated Pediatric Risk of Mortality score

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Sources of variability on the estimate of treatment effect in the PROWESS trial: implications for the design and conduct of future studies in severe sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

Fresh whole blood versus reconstituted blood for pump priming in heart surgery in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960411-5

7 January 2021

10.1016/S0140-6736(07)60411-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17350452%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference